|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US3941763A
(en)
|
1975-03-28 |
1976-03-02 |
American Home Products Corporation |
PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates
|
|
US4263428A
(en)
|
1978-03-24 |
1981-04-21 |
The Regents Of The University Of California |
Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
|
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
EP0088046B1
(de)
|
1982-02-17 |
1987-12-09 |
Ciba-Geigy Ag |
Lipide in wässriger Phase
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
EP0143949B1
(en)
|
1983-11-01 |
1988-10-12 |
TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION |
Pharmaceutical composition containing urokinase
|
|
US5217866A
(en)
|
1985-03-15 |
1993-06-08 |
Anti-Gene Development Group |
Polynucleotide assay reagent and method
|
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
|
JP2528107B2
(ja)
|
1985-03-15 |
1996-08-28 |
サマ−トン，ジエ−ムス |
ポリヌクレオチド測定試薬と方法
|
|
US5521063A
(en)
|
1985-03-15 |
1996-05-28 |
Antivirals Inc. |
Polynucleotide reagent containing chiral subunits and methods of use
|
|
US5166315A
(en)
|
1989-12-20 |
1992-11-24 |
Anti-Gene Development Group |
Sequence-specific binding polymers for duplex nucleic acids
|
|
US4737456A
(en)
|
1985-05-09 |
1988-04-12 |
Syntex (U.S.A.) Inc. |
Reducing interference in ligand-receptor binding assays
|
|
US5525491A
(en)
|
1991-02-27 |
1996-06-11 |
Creative Biomolecules, Inc. |
Serine-rich peptide linkers
|
|
US5714331A
(en)
|
1991-05-24 |
1998-02-03 |
Buchardt, Deceased; Ole |
Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
|
|
US5539082A
(en)
|
1993-04-26 |
1996-07-23 |
Nielsen; Peter E. |
Peptide nucleic acids
|
|
US5527675A
(en)
|
1993-08-20 |
1996-06-18 |
Millipore Corporation |
Method for degradation and sequencing of polymers which sequentially eliminate terminal residues
|
|
DE4331012A1
(de)
|
1993-09-13 |
1995-03-16 |
Bayer Ag |
Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik
|
|
US5786571A
(en)
|
1997-05-09 |
1998-07-28 |
Lexmark International, Inc. |
Wrapped temperature sensing assembly
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
US20060228364A1
(en)
*
|
1999-12-24 |
2006-10-12 |
Genentech, Inc. |
Serum albumin binding peptides for tumor targeting
|
|
JP2003518075A
(ja)
|
1999-12-24 |
2003-06-03 |
ジェネンテック・インコーポレーテッド |
生理活性化合物の消失半減期延長のための方法及び組成物
|
|
US20040001827A1
(en)
*
|
2002-06-28 |
2004-01-01 |
Dennis Mark S. |
Serum albumin binding peptides for tumor targeting
|
|
DE05733048T1
(de)
|
2004-04-06 |
2007-05-10 |
Affibody Ab |
Serumalbuminbindende peptidkonjugate zur arzneimittelherstellung
|
|
GB0412181D0
(en)
|
2004-06-01 |
2004-06-30 |
Celltech R&D Ltd |
Biological products
|
|
KR20070073886A
(ko)
|
2004-10-05 |
2007-07-10 |
제넨테크, 인크. |
독성이 감소된 치료제
|
|
US8992928B2
(en)
|
2006-02-11 |
2015-03-31 |
Victor Raso |
Isolated monoclonal antibody or antigen-binding fragment that cleaves octanoylated native ghrelin
|
|
GB0621973D0
(en)
|
2006-11-03 |
2006-12-13 |
Philogen Spa |
Binding molecules and uses thereof
|
|
US8937153B2
(en)
|
2007-07-31 |
2015-01-20 |
Affibody Ab |
Compositions, methods and uses
|
|
US9181327B2
(en)
|
2008-01-07 |
2015-11-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-HIV domain antibodies and method of making and using same
|
|
US20100075897A1
(en)
*
|
2008-09-23 |
2010-03-25 |
Jinan University |
Method for sustainedly releasing bioactive peptides and application thereof
|
|
DK2437767T3
(en)
|
2009-06-01 |
2015-09-28 |
Medimmune Llc |
MOLECULES WITH EXTENDED half-lives and uses thereof
|
|
WO2011156328A1
(en)
*
|
2010-06-08 |
2011-12-15 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
|
WO2012004384A2
(en)
|
2010-07-09 |
2012-01-12 |
Affibody Ab |
Polypeptides
|
|
BR112013029892A2
(pt)
|
2011-05-21 |
2016-12-20 |
Macrogenics Inc |
polipeptídeo, molécula de ligação a antígeno, diacorpo e uso de uma porção polipeptídica de uma proteína de ligação a soro desimunizada
|
|
WO2012175740A1
(en)
|
2011-06-23 |
2012-12-27 |
Ablynx Nv |
Immunoglobulin single variable domains directed against ige
|
|
US20150044208A1
(en)
|
2011-09-23 |
2015-02-12 |
Technophage, Investigaçäo E Desenvolvimento Em Biotecnologia, Sa |
Modified Albumin-Binding Domains and Uses Thereof to Improve Pharmacokinetics
|
|
CA2849409A1
(en)
|
2011-09-23 |
2013-03-28 |
Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa |
Anti-tumor necrosis factor-alpha agents and uses thereof
|
|
HK1208155A1
(en)
|
2012-03-28 |
2016-02-26 |
Amylin Pharmaceuticals, Llc |
Transmucosal delivery of engineered polypeptides
|
|
EP3563872A1
(en)
*
|
2012-04-05 |
2019-11-06 |
Massachusetts Institute Of Technology |
Immunostimulatory compositions and methods of use thereof
|
|
WO2013180295A1
(ja)
|
2012-06-01 |
2013-12-05 |
日本電信電話株式会社 |
パケット転送処理方法およびパケット転送処理装置
|
|
EP2839842A1
(en)
|
2013-08-23 |
2015-02-25 |
MacroGenics, Inc. |
Bi-specific monovalent diabodies that are capable of binding CD123 and CD3 and uses thereof
|
|
US9300829B2
(en)
|
2014-04-04 |
2016-03-29 |
Canon Kabushiki Kaisha |
Image reading apparatus and correction method thereof
|
|
EP2940128A1
(en)
|
2014-04-30 |
2015-11-04 |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Adenovirus comprising an albumin-binding moiety
|
|
ES2962694T3
(es)
|
2014-05-02 |
2024-03-20 |
Momenta Pharmaceuticals Inc |
Composiciones y procedimientos relacionados con construcciones de Fc manipuladas
|
|
US10774119B2
(en)
|
2014-05-22 |
2020-09-15 |
Pieris Pharmaceuticals Gmbh |
Specific-binding polypeptides and uses thereof
|
|
WO2015193417A1
(en)
*
|
2014-06-18 |
2015-12-23 |
Prorec Bio Ab |
Prolactin receptor antagonists for treatment of glioblastoma
|
|
US20170224777A1
(en)
|
2014-08-12 |
2017-08-10 |
Massachusetts Institute Of Technology |
Synergistic tumor treatment with il-2, a therapeutic antibody, and a cancer vaccine
|
|
BR112017009845A2
(pt)
|
2014-11-10 |
2018-01-16 |
Del Mar Pharmaceuticals |
dianidrogalactitol juntamente com radiação para tratar carcinoma de célula não pequena dos pulmões e glioblastoma multiforme
|
|
KR20180012856A
(ko)
*
|
2015-06-12 |
2018-02-06 |
매카이 메디컬 파운데이션 더 프레즈비티리언 처치 인 타이완 매카이 메모리얼 호스피탈 |
면역반응의 조절을 위한 방법 및 폴리펩타이드
|
|
EP3665202A1
(en)
|
2017-08-09 |
2020-06-17 |
Massachusetts Institute Of Technology |
Albumin binding peptide conjugates and methods thereof
|